Impact of Adherence Education and Monitoring on Community Pharmacy Star Ratings and Patient Satisfaction

Not Applicable

Completed

• Conditions: Adherence, Patient
• Interventions: Behavioral: Adherence monitoring and education

• Registration Number: NCT03848884
• Lead Sponsor: Virginia Commonwealth University

Brief Summary

Does monthly adherence monitoring and education by a pharmacy resident impact Kroger star ratings, compared to the current standard?

Detailed Description

To evaluate if a monthly adherence monitoring and education service impacts the percent of patients adherent to oral diabetes and renin-angiotensin system antagonists (RASA) medications based on star ratings. It will also evaluate patient satisfaction of the adherence monitoring and education service, using a standard questionnaire.

Study Timeline

• Study First Submitted: 2019-02-14
• Study First Submitted QC: 2019-02-19
• Study First Posted: 2019-02-21
• Study Start: 2019-03-01
• Status Verified: 2019-10
• Primary Completion: 2019-10-16
• Study Completion: 2019-10-16
• Last Update Submitted: 2019-10-16
• Last Update Posted: 2019-10-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

1. 18 years or older
2. Patients pre-identified by Kroger analytics in ClinicalQ - Patients with PDC < 80%
3. Patient taking oral diabetes medications and/or RASA medications (ACE-I, ARB, direct renin inhibitor)

Exclusion Criteria

1. Patients who are enrolled in MedSync or Autorefill program
2. Patients who are lost to follow-up
3. Incomplete/missing documentation of an encounter
4. Prisoners, children

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Adherence monitoring and education	Adherence monitoring and education	-

Primary Outcome Measures

Name	Time	Method
Adherence in oral diabetes medications determined by star ratings	Baseline to 6 months	Determine change in patients who are adherent to oral diabetes medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.
Adherence in renin-angiotensin system antagonists (RASA) medications determined by star ratings	Baseline to 6 months	Determine change in patients who are adherent to RASA medications, determined by pharmacy star ratings in adherence measures; pharmacy analytics determines the star rating measure (on a scale of 1 to 5 stars, with 5 being the highest) before and after the study. A student t-test will be used to determine if there is a difference.

Secondary Outcome Measures

Name	Time	Method
Change in proportion of days covered (PDC)	Baseline to 6 months	Determine change in PDC after monthly follow-up on medication adherence and education; pharmacy analytics determines patient PDC in normal practice. The mean PDC for each patient at the end of the six-month study period will be compared to the baseline using a student t-test.

Trial Locations

Locations (1)

Virginia Commonwealth University; 🇺🇸 Richmond, Virginia, United States